SCHEMBL6693479

SCHEMBL6693479

COc1cccc(CNc2cc(NCc3cccc(Cl)c3)cc(C(F)(F)F)c2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
MAPT P10636 3/20 0.59
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.48
LMNA P02545 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
MAPK1 P28482 1/20 0.47
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 1/20 0.47
POLB P06746 1/20 0.47
HIF1A Q16665 1/20 0.46
ABL1 P00519 1/20 0.46
EGFR P00533 1/20 0.46
CDK1 P06493 1/20 0.46
CNR2 P34972 1/20 0.46
CHRM2 P08172 1/20 0.45
UTS2R Q9UKP6 1/20 0.45
MITF O75030 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6693473 0.92 MEN1 (0.56) MEN1KMT2AMAPTGAAKDM4E
SCHEMBL6693899 0.88 P2RX1 (0.54) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL6690726 0.88 MAPT (0.52) MEN1KMT2AMAPTGAAKDM4E
SCHEMBL6693492 0.86 MAPT (0.69) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL6692115 0.83 MEN1 (0.47) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL631899 0.82 MAPT (0.71) MEN1KMT2AMAPTSMN1; SMN2GAA
SCHEMBL6694928 0.81 P2RX1 (0.45) MEN1KMT2AMAPTHTTNPSR1
SCHEMBL6695951 0.80 P2RX1 (0.46) MEN1KMT2AMAPTSMN1; SMN2HTT
SCHEMBL10925112 0.77 MAPT (0.60) MEN1KMT2AMAPTGAALMNA
SCHEMBL6695006 0.77 MAPT (0.68) MEN1KMT2AMAPTSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 MEN1 960/4885KMT2A 998/4885MAPT 3951/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.